Pharmaceutical

Generalized Pustular Psoriasis (GPP) drugs in development, 2024

GlobalData tracks 6 drugs in development for Generalized Pustular Psoriasis (GPP) by five companies/universities/institutes. The top development phase for Generalized Pustular Psoriasis (GPP) is preclinical, with two drugs in that stage.

Aug 31, 2024 - 04:00
GlobalData tracks 6 drugs in development for Generalized Pustular Psoriasis (GPP) by five companies/universities/institutes. The top development phase for Generalized Pustular Psoriasis (GPP) is preclinical, with two drugs in that stage.
Read the original article

Tags:

Previous Article

Atypical Teratoid Rhabdoid Tumor drugs in development, 2024

Next Article

Frontotemporal Dementia (FTD) drugs in development, 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AdAlta and SYNthesis to form AdCella for advanced cancer treatments

AdAlta and SYNthesis to form AdCella for advanced cance...

Apr 9, 2024

Opinion: I’m a doctor who specializes in treating leprosy. Here’s what I want you to know

Opinion: I’m a doctor who specializes in treating lepro...

Aug 23, 2023

Listen: Explaining the E.U.’s pharma overhaul, Lilly’s booming business, & a long-awaited drug approval

Listen: Explaining the E.U.’s pharma overhaul, Lilly’s ...

Apr 27, 2023